Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 212 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: OUD Clear all

Conditions: Opioid Use Disorder
Interventions: ED-LINC; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Substance Use Disorders, Recidivism
Interventions: Adolescent Community Reinforcement Approach, Assertive Continuing Care, Trauma Affect Regulation Guide for Education and Therapy, Motivational Interviewing, Opioid Education Workbook; Behavioral · Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 15 Years to 25 Years
Enrollment: 215 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Olympia, Washington

Conditions: Alcohol Use Disorder, Opioid Use Disorder
Interventions: TMS Low-Dose, TMS High-Dose; Device
Lead sponsor: Washington State University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Community Reinforcement And Family Training, Family Health, Substance-Related Disorders
Interventions: Digital Tutorial overview, Digital Tutorial plus training Materials, Digital Tutorial plus training Materials plus feedback and Coaching; Behavioral
Lead sponsor: We The Village, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid-Related Disorders, Buprenorphine, Social Stigma, Rural Health Services
Interventions: Stigma-reduction training, Placebo; Behavioral
Lead sponsor: Ohio University; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Obsessive-Compulsive Disorder
Interventions: Ketamine, Naltrexone Pill, Placebo pill; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Opioid-use Disorder, Pregnancy Related
Interventions: Perinatal Opioid Use Disorder Education and Enhanced Perinatal Care; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Price, Utah

Conditions: Opioid Use Disorder, Chronic Pain
Interventions: Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention (ACT + MBRP), Enhance Usual Care (EUC); Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Albuquerque, New Mexico

Conditions: Opioid-use Disorder
Interventions: Patient Navigation, Buprenorphine; Behavioral · Drug
Lead sponsor: Friends Research Institute, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 373 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Opioid Use Disorder
Interventions: [11C]-PHNO, Calcitriol, Placebo Control, PET Scan; Drug · Dietary Supplement · Other + 1 more
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Chronic Pain, Opioid Use Disorder
Interventions: Emotional Awareness and Expression Therapy (EAET); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Opioid Use Disorder
Interventions: Neurocognitive battery, fNIRS; Diagnostic Test
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 60 Years
Enrollment: 192 participants
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Opioid Use Disorder, Depressive Disorder
Interventions: Ketamine Hydrochloride; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Substance Use
Interventions: Risk Prevention Services + Housing, Risk Prevention Services Only; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Standard of Care, Standard of Care + CBT4CBT, Standard of Care + CBT4CBT + RC
Interventions: CBT4CBT, RC, Sandard of care; Behavioral
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Opioid-use Disorder, Recidivism
Interventions: NIATx Coaching, ECHO; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Opioid Use Disorder, Healthy Controls Group - Age and Sex-matched
Interventions: follow up interviews for 12 months to determine opioid use; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 60 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Opioid Use Disorder, Chronic Pain
Interventions: Patient-Oriented Dosing (POD), Pain Self-Management (PSM), Usual Care, Standard Buprenorphine Dosing Condition; Drug · Behavioral
Lead sponsor: Erin Winstanley; Other
Eligibility: 18 Years and older
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 13
States / cities: Baltimore, Maryland • Dundalk, Maryland • Hagerstown, Maryland + 6 more

Conditions: Opioid Use Disorder
Interventions: NIATx; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Opioid-Related Disorders
Interventions: Youth Opioid Recovery Support; Behavioral
Lead sponsor: Potomac Health Foundations; Other
Eligibility: 18 Years to 26 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Opioid Use Disorder
Interventions: referral to telehealth treatment, referral to in person treatment; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 528 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: El Centro, California • Sacramento, California • Sylmar, California

Conditions: HIV Infections, Opioid Use
Interventions: [18F]NOS; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Loneliness, Opioid Use Disorder
Interventions: Marigold Mobile Peer Support Intervention, Resources; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Opioid-use Disorder
Interventions: TM buprenorphine, SUBLOCADE; Drug
Lead sponsor: Indivior Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Berlin, New Jersey

Search by objective public record fields.

The Emergency Department Longitudinal Integrated Care

Preventing OUD in Justice-Involved Youth

TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families

Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial

Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine

Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System

Emotional Awareness and Expression Therapy for Chronic Pain and Opioid Use Disorder

Integrating Brain, Neurocognitive, and Computational Tools in OUD

Ketamine for OUD and Comorbid Depression (OUDCD)

Prevention of OUD: The HOME Project (Housing, Opportunities, Motivation and Engagement)

An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder

Fostering MAT Use in Justice Populations

Opioid Use Disorder and Pain

Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment

Expanding Medication-Assisted Therapies in Central Asia

Youth Opioid Recovery Support: A Developmentally-specific Intervention for Home Delivery of Extended Release Naltrexone

Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department

Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls

Improving Social Connectedness Through Digital Health to Enhance Recovery From OUD Among the Justice Involved Population

SUBLOCADE Rapid Initiation Study